| Title: | Prognosis and evaluation of immune-related diseases - PANAMA. |
| Lead Institution: | Erasmus MC |
| Principal investigator: |
Application 176897
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
About
The immune system contributes to three major leading causes of disability and death - cardiovascular disease, cancer and autoimmune diseases, and so adds greatly to the societal diseases burden. Altered signaling within the immune system, specifically through proteins called immune checkpoints which are associated with T-cell activity, has been implicated in disease onset and severity in all three cases. Considering that all three disease entities can be based on genetic predisposition, whether inherited or acquired, the contribution of genetic variances in immune checkpoints to the development of worsening of cardiovascular disease, cancer or autoimmune disease remains to be fully investigated. Therefore, our research question rings ''Do immune checkpoint-associated genetic variances affect outcome of cardiovascular disease, cancer or autoimmune disease?''. Using the UK Biobank, the aim to conduct a three-year project with data from over 500.000 individuals. Our first step will be to will integrate comprehensive data, such as genetic, environmental, behavioral factors, laboratory indicators, imaging data and omics data, to discover which genetic variances can contribute to onset and development of cardiovascular disease, cancer of autoimmune disease. Following the identification of these variances, we will set out to determine which factors could improve risk prediction, be potential biomarkers for early diagnosis or prognosis assessment. Additionally, this could provide information on the mechanisms behind the diseases and highlight potential therapeutic targets.1 Publication
| Pub ID | Title | Author(s) | Year | Journal |
|---|---|---|---|---|
| 19389 | Framingham risk score associates with incident cancer and heart failure | Pieter F van den Berg (+16) | 2025 | European Journal of Preventive Cardiology |
Enabling scientific discoveries that improve human health